Phenotypic signatures of genetic frontotemporal dementia
Phenotypic signatures of genetic frontotemporal dementia : Current Opinion in Neurology
Phenotypic signatures of genetic frontotemporal dementia : Current Opinion in Neurology Log in …
Phenotypic signatures of genetic frontotemporal dementia : Current Opinion in Neurology Log in …
G-protein-coupled receptors in CNS: a potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits
Neurodegenerative diseases are a large group of neurological disorders with diverse
etiological and pathological phenomena. However, current therapeutics rely mostly on …
etiological and pathological phenomena. However, current therapeutics rely mostly on …
[HTML][HTML] Phenotypic heterogeneity of monogenic frontotemporal dementia
Frontotemporal dementia (FTD) is a genetically and pathologically heterogeneous disorder
characterized by personality changes, language impairment, and deficits of executive …
characterized by personality changes, language impairment, and deficits of executive …
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers
AP Strafella, NI Bohnen, JS Perlmutter… - Movement …, 2017 - Wiley Online Library
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian
disorders. One current challenge is to identify biomarkers of early changes that may predict …
disorders. One current challenge is to identify biomarkers of early changes that may predict …
The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
Y Huang, N Todd, A Thathiah - Current opinion in pharmacology, 2017 - Elsevier
Highlights•GPCRs are implicated in the pathophysiology of various neurodegenerative
diseases.•Currently available therapies do not cure the discussed neurodegenerative …
diseases.•Currently available therapies do not cure the discussed neurodegenerative …
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study
Genetic forms of frontotemporal dementia are most commonly due to mutations in three
genes, C9orf72, GRN or MAPT, with presymptomatic carriers from families representing …
genes, C9orf72, GRN or MAPT, with presymptomatic carriers from families representing …
Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort
A Kertesz, LC Ang, S Jesso, J MacKinley… - Cognitive and …, 2013 - journals.lww.com
Objective: To specify the presenting symptoms and clinical course of patients with
frontotemporal dementia (FTD) and chromosome 9 open reading frame 72 (C9ORF72) …
frontotemporal dementia (FTD) and chromosome 9 open reading frame 72 (C9ORF72) …
Early-onset dementias: diagnostic and etiological considerations
M Masellis, K Sherborn, PR Neto, DA Sadovnick… - Alzheimer's Research & …, 2013 - Springer
This paper summarizes the body of literature about early-onset dementia (EOD) that led to
recommendations from the Fourth Canadian Consensus Conference on the Diagnosis and …
recommendations from the Fourth Canadian Consensus Conference on the Diagnosis and …
Parkinsonism and frontotemporal dementia: the clinical overlap
Frontotemporal dementia is commonly associated with parkinsonism in several sporadic (ie,
progressive supranuclear palsy, corticobasal degeneration) and familial neurodegenerative …
progressive supranuclear palsy, corticobasal degeneration) and familial neurodegenerative …
Neuroprotective effects of progranulin in ischemic mice
J Tao, F Ji, F Wang, B Liu, Y Zhu - Brain research, 2012 - Elsevier
Progranulin (PGRN) is a widely expressed protein with diverse biological functions. We
generated a transgenic mouse overexpressing PGRN and found significantly elevated …
generated a transgenic mouse overexpressing PGRN and found significantly elevated …